Hap Trading, LLC Invitae Corp Put Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $6,090 - $10,440	14,500 New	14,500 $7.59 Million
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $4,617 - $9,747	-2,700 Reduced 14.59%	15,800 $70,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $5,700 - $25,890	3,000 Added 19.35%	18,500 $102,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $11,928 - $50,456	-5,600 Reduced 26.54%	15,500 $107,000
Q1 2022 May 12, 2022	SELL	$6.28 - $15.59 $67,824 - $168,372	-10,800 Reduced 33.86%	21,100 $419,000

Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $30,870 - $60,207	-2,100 Reduced 6.18%	31,900 $478,000
Q3 2021 Nov 10, 2021	BUY	$24.31 - $33.6 $116,688 - $161,280	4,800 Added 16.44%	34,000 $279,000
Q2 2021 Aug 11, 2021	SELL	$26.09 - $40.4 $315,689 - $488,840	-12,100 Reduced 29.3%	29,200 $286,000
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $6.1 Million - $10.5 Million	-184,400 Reduced 81.7%	41,300 $307,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $8.42 Million - $12.4 Million	215,500 Added 2112.75%	225,700 $4.79 Million
Q2 2020 Aug 10, 2020	BUY	$11.71 - $30.29 $2,342 - $6,058	200 Added 2.0%	10,200 $10,000
Q3 2018 Nov 09, 2018	BUY	$7.54 - $18.31 $75,400 - $183,100	10,000 New	10,000 $5,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.